Skip to Content
Merck
CN

Anaphylactoid reaction to carboplatin: successful "desensitization".

Allergologia et immunopathologia (2003-12-13)
A Moreno-Ancillo, C Domínguez-Noche, A C Gil-Adrados, P M Cosmes, I Duarte, Y Mateos
ABSTRACT

Carboplatin (CP) hypersensitivity reactions have been reported in nearly 12 % of patients treated with this drug. The pathophysiologic mechanisms of these reactions have not been entirely elucidated. Various hypotheses are under discussion. CP hypersensitivity reactions could be IgE-mediated, caused by low-molecular platinum compounds acting as haptens. Platinum salts are also able to release histamine from basophils and mast cells, and some events seem to be non-immune-mediated direct histamine release. We report a case of CP tolerance induction in a 65-year-old man. During the third course of CP he experienced an anaphylactic reaction. Skin testing was negative. Suspecting the possibility of an anaphylactoid reaction due to histamine release, we developed a protocol to induce tolerance. Pre-medication with corticosteroid and antihistaminic was performed before intravenous CP infusion. The bag with CP was first infused 60 ml/h for 30 minutes; the infusion was well tolerated and infusion was continued at 100 ml/h for the next 60 minutes and thereafter at 120 ml/h until the bag was finished. Following this "desensitization", monthly courses of CP using the same protocol have been well tolerated.

MATERIALS
Product Number
Brand
Product Description

Supelco
Chlorpheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
Dexchlorpheniramine maleate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
S-(+)-Chlorpheniramine maleate salt
Sigma-Aldrich
(±)-Chlorpheniramine maleate salt, ≥99% (perchloric acid titration)
Chlorphenamine maleate, European Pharmacopoeia (EP) Reference Standard
Supelco
Chlorpheniramine maleate salt solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®